Correlation Between Corline Biomedical and AlzeCure Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Corline Biomedical and AlzeCure Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Corline Biomedical and AlzeCure Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Corline Biomedical AB and AlzeCure Pharma, you can compare the effects of market volatilities on Corline Biomedical and AlzeCure Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Corline Biomedical with a short position of AlzeCure Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Corline Biomedical and AlzeCure Pharma.

Diversification Opportunities for Corline Biomedical and AlzeCure Pharma

-0.76
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Corline and AlzeCure is -0.76. Overlapping area represents the amount of risk that can be diversified away by holding Corline Biomedical AB and AlzeCure Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AlzeCure Pharma and Corline Biomedical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Corline Biomedical AB are associated (or correlated) with AlzeCure Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AlzeCure Pharma has no effect on the direction of Corline Biomedical i.e., Corline Biomedical and AlzeCure Pharma go up and down completely randomly.

Pair Corralation between Corline Biomedical and AlzeCure Pharma

Assuming the 90 days trading horizon Corline Biomedical AB is expected to generate 1.86 times more return on investment than AlzeCure Pharma. However, Corline Biomedical is 1.86 times more volatile than AlzeCure Pharma. It trades about 0.08 of its potential returns per unit of risk. AlzeCure Pharma is currently generating about -0.27 per unit of risk. If you would invest  1,500  in Corline Biomedical AB on August 30, 2025 and sell it today you would earn a total of  310.00  from holding Corline Biomedical AB or generate 20.67% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Corline Biomedical AB  vs.  AlzeCure Pharma

 Performance 
       Timeline  
Corline Biomedical 

Risk-Adjusted Performance

Mild

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Corline Biomedical AB are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Corline Biomedical unveiled solid returns over the last few months and may actually be approaching a breakup point.
AlzeCure Pharma 

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days AlzeCure Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Corline Biomedical and AlzeCure Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Corline Biomedical and AlzeCure Pharma

The main advantage of trading using opposite Corline Biomedical and AlzeCure Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Corline Biomedical position performs unexpectedly, AlzeCure Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AlzeCure Pharma will offset losses from the drop in AlzeCure Pharma's long position.
The idea behind Corline Biomedical AB and AlzeCure Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Complementary Tools

FinTech Suite
Use AI to screen and filter profitable investment opportunities
Transaction History
View history of all your transactions and understand their impact on performance
AI Portfolio Prophet
Use AI to generate optimal portfolios and find profitable investment opportunities
Global Correlations
Find global opportunities by holding instruments from different markets
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities